In this episode of the Neurology Podcast: Dr. Kathryn Nevel @IUneurodocmom and Dr. Linda Liau @UCLANsgy discuss the use of DCVax-L for the treatment of newly diagnosed and recurrent #glioblastoma. Listen now: https://t.co/FrUH35dtZT Related article: https
@JackNdreu $nwbo hey @citsecurities your attorneys found Adam Feuerstein's, who has no background in medicines, article, but they couldn't find peer [actual scientists, cancer & brain surgeons, phds] reviewed @JAMAOnc article ? Here is link for you --&
RT @peter_brit: Meaningful increases in the long-term tails of the survival curves in both nGBM and rGBM were also observed. GROUNDBREAKIN…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
RT @rago_carlo: Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly diagnosed and recurrent glioblastoma? Preliminary data showed a 500% survival increase in rGBM when combined with a checkpoint https
Are $MRNA, $BNTX and $GRTS investors aware of the $NWBO Phase 3 cancer vaccine win (increased survival over 100%) in newly diagnosed and recurrent glioblastoma. Preliminary data showed a 500% survival increase in rGBM when combined with a checkpoint http
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
RT @rago_carlo: @IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both…
@IBD_AGatlin Hi Allison, $NWBO just finished a cancer vaccine Phase 3 which showed a survival increase of over 100% in both newly diagnosed (nGBM) and recurrent (rGBM) glioblastoma . rGBM is a rare disease with unmet need - It is so horrific that there rea
https://t.co/4HogSdIiYp https://t.co/hJ4uOHKbMe $nwbo @alphavestcap Allison: Bio99 summarizes .https://t.co/Uz0j5brCpA
https://t.co/4HogSdIiYp https://t.co/hJ4uOHKbMe $nwbo @alphavestcap
Allison: $nwbo cancer vaccine could be approved in the UK 8/1/23; and FDA by 12/21/23 . SPORE = 50% alive in GBM at 2 years. Contact Dr.Liau. @IBD_AGatlin https://t.co/MTNivDXzFu @alphavestcap https://t.co/mqCmOwxlId https://t.co/bhUDKROm2Z
Allison: $nwbo cancer vaccine could be approved in the UK 8/1/23; and FDA by 12/21/23 . SPORE = 50% alive in GBM at 2 years. Contact Dr.Liau. @IBD_AGatlin @alphavestcap https://t.co/mqCmOwxlId https://t.co/bhUDKROm2Z https://t.co/46GhIRUCeo
RT @AndrewEcker829: @JoshuaJ34395123 @Megohelie1 Hi Josh - I encourage you to read this article in JAMA Oncology regarding the DC-Vax-L pha…
https://t.co/bhUDKROm2Z https://t.co/QNc8GDEc8s $nwbo @alphavestcap
@JoshuaJ34395123 @Megohelie1 Hi Josh - I encourage you to read this article in JAMA Oncology regarding the DC-Vax-L phase 3 clinical trial results. The results when this is combined with additional treatments like checkpoint inhibitors are also really exci
RT @Arhdan9: @SquawkCNBC @US_FDA @megtirrell $NWBO is a tiny company trading OTC, but huge and more significant than a major pharma with a…
@SquawkCNBC @US_FDA @megtirrell $NWBO is a tiny company trading OTC, but huge and more significant than a major pharma with a breakthrough designation, to report because it will be part of solutions to kill all #Cancers. https://t.co/Ji6ltP29NJ https://t
@AmericanCancer Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma #DCVaxL $NWBO A Phase 3 Prospective Externally Controlled Cohort Trial. h
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
$NWBO #NWBO
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @BIO99_BIO99: JAMA Oncology retweeting the DCVax phase 3 trial. I analyzed views of this article two weeks ago concluding that it was th…
RT @Ali_boy_180: . . . 👏👏👏👏 JAMA ONCOLOGY 👏👏👏👏 . . #DCVax-L #GBM #Glioblastoma #murcidencel . #NWBO $NWBO #neuros…
RT @Ali_boy_180: . . . 👏👏👏👏 JAMA ONCOLOGY 👏👏👏👏 . . #DCVax-L #GBM #Glioblastoma #murcidencel . #NWBO $NWBO #neuros…
RT @Ali_boy_180: . . . 👏👏👏👏 JAMA ONCOLOGY 👏👏👏👏 . . #DCVax-L #GBM #Glioblastoma #murcidencel . #NWBO $NWBO #neuros…
. . . 👏👏👏👏 JAMA ONCOLOGY 👏👏👏👏 . . #DCVax-L #GBM #Glioblastoma #murcidencel . #NWBO $NWBO #neuroscience #science . #Neurosurgery #oncology #BrainCancer
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @KauriCapital: @andrewpannu One of them will buy $NWBO https://t.co/Ji7W5ADn9h
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma https://t.co/yfPoLxN5bQ via @JAMAOnc part of @JAMANetwork On close reading this is a very important study
RT @alphavestcap: "... the results ... should be confirmed by a randomised trial."https://t.co/Mgf5WlFZil $nwbo @alphavestcap https://t.c…
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @alphavestcap: "... the results ... should be confirmed by a randomised trial."https://t.co/Mgf5WlFZil $nwbo @alphavestcap https://t.c…
@skleb1234 Sergei: $nwbo could have the best spoofing data vis a vis Citadel et al short 100% .DC VAX L about to go commercial in the U.K. You-WSJ = DOJ warmer. https://t.co/bhUDKROm2Z $nwbo @alphavestcap https://t.co/oECASbVPUD https://t.co/zLIH5dzI1j
"... the results ... should be confirmed by a randomised trial."https://t.co/Mgf5WlFZil $nwbo @alphavestcap https://t.co/bhUDKROm2Z So , knowing that DC VAX L provides longer survival than SOC, does future patient accrual in a SOC placebo group make hu
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @ThomasOwenMcCa1: This is important, Please read!
RT @ThomasOwenMcCa1: This is important, Please read!
"... the results ... should be confirmed by a randomised trial."https://t.co/e0fn87q3Ss $nwbo @alphavestcap https://t.co/bhUDKROTSx So , knowing that DC VAX L provides longer survival that SOC, does future patient accrual in a SOC placebo group make huma
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @BIO99_BIO99: JAMA Oncology retweeting the DCVax phase 3 trial. I analyzed views of this article two weeks ago concluding that it was th…
RT @ThomasOwenMcCa1: This is important, Please read!
RT @BIO99_BIO99: JAMA Oncology retweeting the DCVax phase 3 trial. I analyzed views of this article two weeks ago concluding that it was th…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @BIO99_BIO99: JAMA Oncology retweeting the DCVax phase 3 trial. I analyzed views of this article two weeks ago concluding that it was th…
RT @andrewcaravello: @cvpayne Interesting to see what happens this week $NWBO #Moonshot #Nakedshorts #COUNTERFEITSHARES
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @BIO99_BIO99: JAMA Oncology retweeting the DCVax phase 3 trial. I analyzed views of this article two weeks ago concluding that it was th…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @apwriter: Even JAMA is tired of the bullshit. Look what they just tweeted. Squeeze. $nwbo
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @BIO99_BIO99: JAMA Oncology retweeting the DCVax phase 3 trial. I analyzed views of this article two weeks ago concluding that it was th…
RT @Nina_kd: $NWBO is JAMA'n!
RT @Dave46217976: #DCVAX $NWBO
@NeurologyToday (per Dr. Brem) "One of the 'Best Advances of 2022.'" $nwbo under $7? Under $.70? Lol.
RT @gcelisdelvalle: $NWBO #NWBO
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…